Advertisement

Picture EBD Group BioPharm America 2019 Boston September 600x60px
Organisation › Details

Loxo Oncology Inc. (Nasdaq: LOXO)

Loxo Oncology is a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers. Our pipeline focuses on cancers that are uniquely dependent on single gene abnormalities, such that a single drug has the potential to treat the cancer with dramatic effect. We believe that the most selective, purpose-built medicines have the highest probability of maximally inhibiting the intended target, thereby delivering best-in-class disease control and safety. Our management team seeks out experienced industry partners, world-class scientific advisors and innovative clinical-regulatory approaches to deliver new cancer therapies to patients as quickly and efficiently as possible. *

 

Period Start 2017-07-31 existent
Products Industry larotrectinib (LOXO-101)
  Industry 2 BAY 2731954 (LOXO-195)
Person Person Bilenker, Josh (Loxo Oncology 201811 CEO)
     
  Street 281 Tresser Blvd.
  City 06901 Stamford, CT
  Tel +1-203-653-3880
    Address record changed: 2017-11-22
     
     
    * Document for �About Section�: Loxo Oncology, Inc.. (11/14/17). "Press Release: Loxo Oncology Announces Global Development and Commercialization Partnership with Bayer for Larotrectinib and LOXO-195". Stamford, CT.
     
   
Record changed: 2019-02-18

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x112px

More documents for Loxo Oncology Inc. (Nasdaq: LOXO)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica iito 600x60px




» top